CFA
EVH icon

Compass Financial Advisors’s Evolent Health EVH Stock Holding History

Compass Financial Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,495
Closed -$373K – 28
2023
Q1 		$373K Buy
11,495
+2,875
+33% +$90.9K 0.47% 72
2022
Q4 		$242K Buy
+8,620
New +$247K 0.33% 101
2022
Q2 		– Sell
-6,791
Closed -$219K – 129
2022
Q1 		$219K Sell
6,791
-14,435
-68% -$378K 0.24% 125
2021
Q4 		$587K Buy
+21,226
New +$609K 0.65% 59

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Compass Financial Advisors's EVH Position: Q2 2023 in Review

Compass Financial Advisors sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 11,495 shares — an estimated $373K sold.

Compass Financial Advisors first reported a position in EVH in Q4 2021 and held it in 4 quarters. The position peaked at $587K in Q4 2021. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • Compass Financial Advisors reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
  • Compass Financial Advisors sold 11,495 Evolent Health shares in Q2 2023, an estimated $373K.
  • Compass Financial Advisors first reported a position in Evolent Health in Q4 2021 and held it in 4 quarters.
  • Compass Financial Advisors's Evolent Health position peaked at $587K in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.